Breaking News

Financial Report: BASi

Service revenue up 12% in the quarter

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

BASi 3Q Revenues: $8.5 million (+5%) 3Q Earnings: $0.4 million (+45%) YTD Revenues: $25.0 million (+17%) YTD Earnings: $1.2 million (loss of $2.4 million YTD10) Comments: Service revenue accounted for $6.7 million in the quarter, up 12%. Product revenue was down 14% to $1.7 million. Anthony Chilton, president and chief executive officer, said, “Pricing is improving, although it still lags pre-recession levels, and the volume of studies and number of samples to assay have increased steadily ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters